Showing results (1161-1170 of 2,747) with videos related to

Sort By:
Pageof 275
Clinical and Experimental Nephrology|March 15, 2014
Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritisTadaatsu Imaizumi, Tomomi Aizawa, Ryo Hayakari, et al.
Clinical and Experimental Nephrology|March 18, 2014
Apolipoprotein AII levels are associated with the UP/UCr levels in idiopathic steroid-sensitive nephrotic syndromeTakahiro Kanai, Takanori Yamagata, Takane Ito, et al.
Clinical and Experimental Nephrology|April 15, 2014
Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damageShinsuke Isobe, Naro Ohashi, Tomoyuki Fujikura, et al.
Clinical and Experimental Nephrology|January 4, 2017
Management of secondary hyperparathyroidism: how and why?Hirotaka Komaba, Takatoshi Kakuta, Masafumi Fukagawa
Clinical and Experimental Nephrology|February 13, 2017
Effects of tolvaptan in patients with chronic kidney disease and chronic heart failureMari Katsumata, Nobuhito Hirawa, Koichiro Sumida, et al.
Clinical and Experimental Nephrology|December 19, 2007
MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomyNoriko Ogawa, Shozo Yano, Yuko Yamane, et al.
Clinical and Experimental Nephrology|October 15, 2016
Does significant renal ablation truly and invariably lead to hyperfiltration and progressive chronic kidney disease?Andrew Wang, Ramin Sam
Clinical and Experimental Nephrology|November 5, 2016
Minimal change nephrotic syndrome and prohibitin-2 gene polymorphismKeisuke Sugimoto, Tomoki Miyazawa, Kohei Miyazaki, et al.
Clinical and Experimental Nephrology|October 21, 2016
Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure ratsTakayo Miyakogawa, Genta Kanai, Ryoko Tatsumi, et al.
Clinical and Experimental Nephrology|February 12, 2014
Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patientsNadir Alpay, Abdullah Ozkok, Yasar Caliskan, et al.
Pageof 275